Search results

*[[leukemia]]s ** [[acute myeloid leukemia]]

...myelofibrosis]] but not secondary erythrocytosis or [[chronic myelogenous leukemia]].<ref name="pmid15858187">{{cite journal| author=Kralovics R, Passamonti F

...s [[erythema multiforme]]. Sweet's syndrome may herald the appearance of [[leukemia]]."<ref>{{MeSH}}</ref>

...hers; both had inhibitory action, ''in vitro'', on breast cancer but not leukemia. <ref>{{citation

*[http://www.cllf.org/ Cammy Lee Leukemia Foundation]

...ssive increase in the number of [[eosinophil]]s in the blood, mimicking [[leukemia]], and extensive eosinophilic infiltration of the various organs. <ref name

...ological neoplasms]] due to the risk of transformation to [[acute myeloid leukemia]]. ...e disease, accelerates [[apoptosis]] of the blood cells. If it converts to leukemia, an additional mutation takes place. <ref>{{citation

...Holden says he likes his brother Allie, who died several years before of [[leukemia]]. Throughout the novel, Holden reveals clues that show that Holden cannot * Holden’s brother who died of leukemia

...other genes and cause leukemia. Fortunately the risk seems small, and the leukemia mostly curable. With larger numbers of patients treated and followed throug

...ther drugs, in the treatment of or in remission maintenance programs for [[leukemia]]."<ref>{{MeSH|Mercaptopurine}}</ref> ...mainly in the treatment of leukemia, especially acute non-lymphoblastic [[leukemia]]. Cytarabine is an antimetabolite antineoplastic agent that inhibits the s

...ns can be elevated (usually above 0.5%) in children and adults affected by leukemia and several types of anemia."<ref>{{MeSH|Hemoglobin F}}</ref>

...ia]], [[idiopathic neutropenia]], neutropenia secondary to [[acute myeloid leukemia]] treatment]], prevention of neutropenia from cancer chemotherapy, mobiliza

Most recipients of HSCTs are [[leukemia]] patients or others who would benefit from treatment with high doses of [[ ...ft-versus-host disease after an allogeneic transplant have a lower risk of leukemia relapse. This is due to a therapeutic immune reaction of the grafted donor

**Promyelocytic Leukemia

...[[polymyalgia]], particularly in patients with myelomas; lymphomas; acute leukemia; malignant histiocytosis; and tumors of the colon, pancreas, prostate, and

...dx.doi.org/10.1016/j.peptides.2007.06.014 "Induction of apoptosis in human leukemia K562 cells by cyclic lipopeptide from Bacillus subtilis natto T-2."]</ref> ...ubtilis'' do have anti-tumor activity and can inhibit the proliferation of leukemia cells by inducing their apoptosis. With further research, this ''B. subtil

...omegalovirus]] infections in transplant recipients, [[chronic lymphocytic leukemia]]; [[Kawasaki syndrome]], infection in neonates, and [[idiopathic thrombocy

...e and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the origin

description of leukemia" editorial in ''The Haematology Journal'' (2001) 2:1]</ref>

...collectively to determine the phenotype of dominant cell populations in [[leukemia]]s and [[lymphoma]]s<ref>{{citation